Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression | Zendy

Peter J. Schmidt | Zendy; Robert C. Daly | Zendy; Miki Bloch | Zendy; M. J. Smith | Zendy; Merry A. Danaceau | Zendy; Linda Simpson St. Clair | Zendy; Jean H. Murphy | Zendy; Nazli Haq | Zendy; David R. Rubinow | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression

Author(s) -

Peter J. Schmidt,

Robert C. Daly,

Miki Bloch,

M. J. Smith,

Merry A. Danaceau,

Linda Simpson St. Clair,

Jean H. Murphy,

Nazli Haq,

David R. Rubinow

Publication year - 2005

Publication title -

archives of general psychiatry

Language(s) - English

Resource type - Journals

eISSN - 1538-3636

pISSN - 0003-990X

DOI - 10.1001/archpsyc.62.2.154

Subject(s) - hamilton rating scale for depression , depression (economics) , placebo , rating scale , medicine , psychology , major depressive disorder , psychiatry , mood , developmental psychology , alternative medicine , pathology , economics , macroeconomics

Alternative and over-the-counter medicines have become increasingly popular choices for many patients who prefer not to take traditional antidepressants. The adrenal androgen and neurosteroid dehydroepiandrosterone (DHEA) is available as over-the-counter hormonal therapy and previously has been reported to have antidepressant-like effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research